DT MedTech (DTM) received FDA 510(k) clearance to market the Hintermann Series H2™ Total Ankle Replacement, a semi-constrained cemented prosthesis for primary or revision surgery. Limited launch is slated for late 4Q17, ex-U.S., as it has already secured CE Mark Approval.
Hintermann Series H2 is also indicated to treat failed total ankle replacement or non-union/mal-union of the ankle arthrodesis, with sufficient bone stock.
Series H2 will be distributed in the U.S. by HealthLink Europe, based in Raleigh, North Carolina, and through specialized and select distributors. DTM already markets Hintermann Series H3™, a mobile-bearing ankle, in over 30 countries ex-U.S., where the product has over 17 years of established clinical efficacy.
Source: DT MedTech, LLC
Image courtesy of DT MedTech, LLC
DT MedTech (DTM) received FDA 510(k) clearance to market the Hintermann Series H2™ Total Ankle Replacement, a semi-constrained cemented prosthesis for primary or revision surgery. Limited launch is slated for late 4Q17, ex-U.S., as it has already secured CE Mark Approval.
Hintermann Series H2 is also indicated to treat failed total ankle...
DT MedTech (DTM) received FDA 510(k) clearance to market the Hintermann Series H2™ Total Ankle Replacement, a semi-constrained cemented prosthesis for primary or revision surgery. Limited launch is slated for late 4Q17, ex-U.S., as it has already secured CE Mark Approval.
Hintermann Series H2 is also indicated to treat failed total ankle replacement or non-union/mal-union of the ankle arthrodesis, with sufficient bone stock.
Series H2 will be distributed in the U.S. by HealthLink Europe, based in Raleigh, North Carolina, and through specialized and select distributors. DTM already markets Hintermann Series H3™, a mobile-bearing ankle, in over 30 countries ex-U.S., where the product has over 17 years of established clinical efficacy.
Source: DT MedTech, LLC
Image courtesy of DT MedTech, LLC
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.